1. Home
  2. HIW vs OGN Comparison

HIW vs OGN Comparison

Compare HIW & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HIW

Highwoods Properties Inc.

HOLD

Current Price

$25.58

Market Cap

2.9B

Sector

Real Estate

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$6.79

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIW
OGN
Founded
1978
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.7B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
HIW
OGN
Price
$25.58
$6.79
Analyst Decision
Hold
Hold
Analyst Count
7
5
Target Price
$31.00
$14.10
AVG Volume (30 Days)
1.4M
4.8M
Earning Date
10-28-2025
11-10-2025
Dividend Yield
7.81%
1.14%
EPS Growth
N/A
N/A
EPS
1.16
1.91
Revenue
$811,773,000.00
$6,301,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.57
N/A
P/E Ratio
$22.10
$3.66
Revenue Growth
N/A
N/A
52 Week Low
$24.19
$6.18
52 Week High
$32.76
$17.23

Technical Indicators

Market Signals
Indicator
HIW
OGN
Relative Strength Index (RSI) 27.83 38.36
Support Level $25.46 $6.82
Resistance Level $26.23 $7.14
Average True Range (ATR) 0.58 0.27
MACD -0.01 -0.01
Stochastic Oscillator 3.99 4.73

Price Performance

Historical Comparison
HIW
OGN

About HIW Highwoods Properties Inc.

Highwoods Properties Inc is a real estate investment trust engaged in the acquisition, ownership, management, and leasing of properties in urban areas throughout the Southern United States. In terms of total square footage, the vast majority of the company's real estate portfolio comprises office buildings in terms. Highwoods Properties derives nearly all of its income in the form of rental revenue from the tenants of its buildings. The majority of this revenue comes from its holdings in the urban markets of Atlanta, Raleigh, Nashville, and Tampa. These cities also account for the majority of the square footage under the company's ownership. Highwoods Properties customers include the U.S. Government, financial services firms, industrial supply retailers, and healthcare companies.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: